Ignite Creation Date:
2025-12-24 @ 10:45 PM
Ignite Modification Date:
2025-12-25 @ 8:15 PM
Study NCT ID:
NCT06414135
Status:
RECRUITING
Last Update Posted:
2024-08-15
First Post:
2024-05-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Relmacabtagene Autoleucel for the Treatment of Systemic Sclerosis
Sponsor:
Liangjing Lu
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-12
Start Date Type:
ACTUAL
Primary Completion Date:
2025-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-04
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-06
First Submit QC Date:
None
Study First Post Date:
2024-05-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-14
Last Update Post Date:
2024-08-15
Last Update Post Date Type:
ACTUAL